William J. Hoskins

Memorial Sloan-Kettering Cancer Center, New York, New York 10021 U.S.A.

Show Academic Trajectory

Ego Network

D-Core

Research Interests

Author Statistics

Experience

Education

Bio

None

Papers140 papers

Sort

By YearBy Citation

John L. Lewis, Jr., MD 1929–2012

Richard R Barakat,William J Hoskins

Gynecologic Oncology, no. 1 (2013): 146

Bibtex

Revolving door of obstruction – An analysis of gynecologic oncology readmission

S Phelps,V Andikyan,J Denesopolis, E Rodriguez,William P Tew, Stephen J Martin,William J Hoskins,Richard R Barakat,D Chi,V Makker

Gynecologic Oncology, (2013)

Bibtex

Cyclin D1 and p57 expression in advanced ovarian epithelial carcinoma: A GOG study

E. Hill,William E. Brady,Michael J. Birrer,Kathleen M. Darcy,William P. McGuire,William J. Hoskins,David P. Warshal, R. D. Drake,Parviz Hanjani,Jean A. Hurteau

Journal of Clinical Oncology, (2011): 5086-5086

Bibtex

The effect of primary cytoreduction on outcomes of patients with FIGO stage IIIC ovarian cancer stratified by the initial tumor burden in the upper abdomen cephalad to the greater omentum

Oliver Zivanovic,Camelia S Sima,Alexia Iasonos,William J Hoskins,Pavani R Pingle,Mario M M Leitao,Yukio Sonoda,Nadeem R Abu-Rustum,Richard R Barakat,Dennis S Chi

Gynecologic Oncology, no. 3 (2010): 351-357

Cited by24WOSEIBibtex

Current academic clinical trials in ovarian cancer: Gynecologic Cancer Intergroup (GCIG) and United States National Cancer Institute (NCI) clinical trials planning meeting, May, 2009

Edward L Trimble,Michael J Birrer,William J Hoskins,Christian Marth, R A Petryshyn, M A Quinn, Gillian M Thomas,H C Kitchener

International Journal of Gynecological Cancer, (2010)

Bibtex

The prognostic value of pretreatment CA 125 in patients with advanced ovarian carcinoma: a Gynecologic Oncology Group study

Kristin K Zorn,Chunqiao Tian, William P McGuire,William J Hoskins,Maurie Markman,Franco M Muggia,Peter G Rose,Robert F Ozols,David Spriggs,Deborah K Armstrong

CANCER, no. 5 (2009): 1028-1035

Cited by24WOSBibtex

The prognostic value of pretreatment CA 125 in patients with advanced ovarian carcinoma

Kristin K Zorn,Chunqiao Tian, William P Mcguire,William J Hoskins,Maurie Markman,Franco M Muggia,Peter G Rose,Robert F Ozols,David R Spriggs,Deborah K Armstrong

CANCER, no. 5 (2009): 1028-1035

Cited by26Bibtex

Primary Surgery for Ovarian Carcinoma

Christina S. Chu,William J. Hoskins,Stephen C. Rubin

The Global Library of Women's Medicine, (2009)

Cited by1Bibtex

Associations between ERBB2 amplification and progression-free survival and overall survival in advanced stage, suboptimally-resected epithelial ovarian cancers: a Gynecologic Oncology Group Study

John Farley,Sartoru Fuchiuji,Kathleen M Darcy,Chunqiao Tian,William J Hoskins, William P McGuire,Parviz Hanjani,David Warshal,Benjamin E Greer,Jerome Belinson,Michael J Birrer

Gynecologic Oncology, no. 3 (2009): 341-347

Cited by22WOSEIBibtex

Prognostic relevance of c-MYC gene amplification and polysomy for chromosome 8 in suboptimally-resected, advanced stage epithelial ovarian cancers: A Gynecologic Oncology Group study

Kathleen M. Darcy,William E. Brady,Jan K. Blancato,Robert B. Dickson,William J. Hoskins, William P. McGuire,Michael J. Birrer

Gynecologic Oncology, no. 3 (2009): 472-479

Cited by25EIWOSBibtex

PROGNOSTIC VALUE OF PRETREATMENT CA-125 IN ADVANCED OVARIAN CARCINOMA: A GYNECOLOGIC ONCOLOGY GROUP STUDY

Kristin K Zorn,Chunqiao Tian, William P Mcguire,William J Hoskins,Maurie Markman,Franco M Muggia,Peter G Rose,Robert F Ozols,David R Spriggs,Deborah K Armstrong

CANCER, no. 5 (2009): 1028-1035

Cited by25Bibtex

Variations in institutional infrastructure, physician specialization and experience, and outcome in ovarian cancer: A systematic review

Andreas du Bois,Justine Rochon,Jacobus Pfisterer,William J. Hoskins

Gynecologic Oncology, no. 2 (2009): 422-436

Cited by196EIWOSBibtex

Prospective Study of the Correlation Between Postoperative Computed Tomography Scan and Primary Surgeon Assessment in Patients With Advanced Ovarian, Tubal, and Peritoneal Carcinoma Reported to Have Undergone Primary Surgical Cytoreduction to Residual Disease 1 cm or Less

D. S. Chi,P. T. Ramirez,J. B. Teitcher,S. Mironov,D. M. Sarasohn,R. B. Iyer,E. L. Eisenhauer,N. R. Abu-Rustum,Y. Sonoda,D. A. Levine, C. L. Brown,C. Aghajanian

Journal of Clinical Oncology, no. 31 (2007): 4946-4951

Cited by32WOSBibtex

Outcomes of octogenarians and nonagenarians in elective major gynecologic surgery

Wayne H. Friedman,Donald G. Gallup,James J. Burke,Edward A. Meister,William J. Hoskins

American Journal of Obstetrics and Gynecology, no. 2 (2006): 547-552

Cited by10EIWOSBibtex

Hervy E. Averette, M.D

William J. Hoskins,Joseph A. Lucci

Gynecologic Oncology, no. 2 (2006): 189-190

EIBibtex

Chapter 35 - Chemotherapy of Ovarian Cancer

Martee L Hensley,William J Hoskins

(2004)

Bibtex

Atlas of Procedures in Gynecologic Oncology: Memorial Sloan-Kettering Cancer Center

Douglas A. Levine,Richard R Barakat,William J Hoskins

International Journal of Gynecological Cancer, no. 6 (2003): 918-919

Bibtex

Erythropoietin improves quality of life—a response

E J Junor,D J Hole, C R Gillis,Colin B Begg,Laura D Cramer,William J Hoskins

(2002)

Bibtex

Screening for Cervical Cancer

Amreen Husain,William J Hoskins

(2002)

Bibtex

Intravaginal high-dose-rate brachytherapy for Stage IB (FIGO Grade 1, 2) endometrial cancer

Kaled M Alektiar,Andrea McKee,Ennapadam Venkatraman,Brady McKee,Micheal J Zelefsky,Boris R Mychalczak,William J Hoskins,Richard R Barakat

International Journal of Radiation Oncology*Biology*Physics, no. 3 (2002): 707-713

Cited by31EIWOSBibtex

View All

Base Info Papers Patents Projects